HPNN: Hop-on Subsidiary Re-Medical enters into Cannabis Transdermal Delivery
Re-Medical will begin the distribution of cannabis transdermal patches in Colorado
Temecula, California, February 25, 2014- Hop-on, Inc (OTC:HPNN.PK) announced today its subsidiary, Re-Medical, Inc., is setting up distribution of cannabis transdermal patches in legal jurisdictions, with the first being Colorado.
Re-Medical's mission is to provide solutions for patients desiring to use cannabis as a nutraceutical alternative to traditional or prescription medications.
Re-Medical is a Hop-on company focused on alternative ways to deliver vitamins, supplements and other healthful products such as cannabis, utilizing transdermal patches. The company has developed and isolated the benefits of cannabis and other vital plant extracts for best patient care. There are an estimated 80+ cannabinoids found in cannabis, each providing distinctive neuropathic effects. The company is currently applying for patents regarding the delivery of cannabis via transdermal patches. Re-Medical patches offer cost effective, accurate and clean delivery of these unique compounds.
Re-Medical’s transdermal patch has a variety of choices for both high THC and high CBD cannabis users to medicate in a precisely dosed, discreet, clean delivery method. Re-Medical offers the high THC and high CBD transdermal patches in 10mg and 20mg doses.
Hop-on, Inc. (HPNN.PK) is a global ODM and OEM manufacturer of electronics, based in the United States. Over the past 20 years, Hop-on has successfully secured essential patents for mobile communications and computing technologies, and is respected for developing the world’s first disposable cell phone. Hop-on's focus on smartphones and innovative mobile device applications is bringing cost friendly solutions to today's demanding world market. Hop-on is also diversified in delivering cannabis remedies. For more information, please visit www.re-medical.com
News 
Market Data 
Discover 
AI
